| 41.14 Data as of May 17 | +1.25 / +3.13%Today’s Change | 32.69 Today|||52-Week Range 44.44 | +0.73% Year-to-Date |
The 5 analysts offering 12-month price forecasts for Haemonetics Corp have a median target of 46.00, with a high estimate of 47.00 and a low estimate of 37.00. The median estimate represents a +11.81% increase from the last price of 41.14.

The current consensus among 8 polled investment analysts is to Hold stock in Haemonetics Corp. This rating has held steady since May, when it was unchanged from a rating.Move your mouse over past
months for detail

Move your mouse over a quarter or year to see how estimates have changed over time.




